IS3994A - An analogous method for the production of indole derivatives - Google Patents

An analogous method for the production of indole derivatives

Info

Publication number: IS3994A
Authority: IS; Iceland
Prior art keywords: production; indole derivatives; analogous method; analogous; indole
Prior art date: 1992-04-16

Application number

IS3994A

Other languages

Icelandic (is)

Inventor

Cugola Alfredo

Gaviraghi Giovanni

Giacobbe Simone

Original Assignee

Glaxo Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-04-16

Filing date

1993-04-15

Publication date

1993-10-17

1993-04-15 Application filed by Glaxo Spa filed Critical Glaxo Spa

1993-10-17 Publication of IS3994A publication Critical patent/IS3994A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Addiction (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)

IS3994A 1992-04-16 1993-04-15 An analogous method for the production of indole derivatives IS3994A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB929208492A GB9208492D0 (en)	1992-04-16	1992-04-16	Heterocyclic compounds

Publications (1)

Publication Number	Publication Date
IS3994A true IS3994A (en)	1993-10-17

Family

ID=10714220

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS3994A IS3994A (en)	1992-04-16	1993-04-15	An analogous method for the production of indole derivatives

Country Status (41)

Country	Link
US (4)	US5373018A (en)
EP (1)	EP0568136A1 (en)
JP (2)	JPH07505407A (en)
KR (1)	KR100264114B1 (en)
CN (1)	CN1042331C (en)
AP (1)	AP480A (en)
AT (1)	AT403917B (en)
AU (1)	AU666927B2 (en)
BE (1)	BE1006343A5 (en)
BG (1)	BG62136B1 (en)
BR (1)	BR1100323A (en)
CA (3)	CA2094076A1 (en)
CH (1)	CH685630A5 (en)
CY (1)	CY2038B1 (en)
CZ (1)	CZ285799B6 (en)
DK (1)	DK169890B1 (en)
ES (1)	ES2105924B1 (en)
FI (1)	FI106198B (en)
FR (1)	FR2690919B1 (en)
GB (2)	GB9208492D0 (en)
GE (1)	GEP19991704B (en)
GR (1)	GR1001619B (en)
HK (1)	HK95797A (en)
HU (2)	HU217964B (en)
IL (1)	IL105412A (en)
IS (1)	IS3994A (en)
IT (1)	IT1265325B1 (en)
LU (1)	LU88248A1 (en)
MX (1)	MX9302195A (en)
MY (1)	MY112232A (en)
NO (1)	NO301879B1 (en)
NZ (1)	NZ247413A (en)
OA (1)	OA10103A (en)
PL (1)	PL176451B1 (en)
RO (1)	RO113242B1 (en)
RU (1)	RU2129544C1 (en)
SE (1)	SE504336C2 (en)
SK (1)	SK281941B6 (en)
TW (1)	TW224457B (en)
WO (1)	WO1993021153A1 (en)
ZA (1)	ZA932642B (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9304500D0 (en) *	1993-03-05	1993-04-21	Glaxo Spa	Heterocyclic compounds
US5519048A (en) *	1993-05-27	1996-05-21	Merrell Pharmaceuticals Inc.	3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
ES2103590T3 (en) *	1993-05-27	1997-09-16	Merrell Pharma Inc	DERIVATIVES OF ACID 3- (INDOL-3-IL) PROPENOIC USABLE AS ANTAGONISTS NMDA.
GB9319243D0 (en) *	1993-09-17	1993-11-03	Glaxo Spa	Heterocyclic compounds
GB9321221D0 (en) *	1993-10-14	1993-12-01	Glaxo Spa	Heterocyclic compounds
TW280819B (en) *	1993-11-17	1996-07-11	Sumitomo Pharma
US5563157B1 (en)	1994-10-31	1999-02-02	Hoecst Marion Roussel Inc	Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
GB9502695D0 (en) *	1995-02-11	1995-03-29	Glaxo Spa	Pharmaceutical composition
GB9504361D0 (en) *	1995-03-04	1995-04-26	Glaxo Spa	Heterocyclic compounds
WO1998011892A1 (en) *	1996-09-17	1998-03-26	The Regents Of The University Of California	Positive ampa receptor modulation to enhance brain neurotrophic factor expression
CN1139572C (en) *	1996-09-30	2004-02-25	阿温蒂斯药物公司	NMDA (N-methyl-D-aspartic acid) antagonists
US5922752A (en) *	1997-06-11	1999-07-13	Hoechst Marion Roussell, Inc.	NMDA (n-methyl-d-aspartate) antagonists
AU749623B2 (en) *	1998-03-26	2002-06-27	Astellas Pharma Inc.	Sustained release preparations
RU2277096C2 (en) *	2000-07-31	2006-05-27	ДАЙНИППОН СУМИТОМО ФАРМА Ко., ЛТД.	Agents against feeble-mindedness comprising derivatives of 2-aryl-8-oxodihydropurine as active component
US20030162825A1 (en) *	2001-11-09	2003-08-28	Sepracor Inc.	D-amino acid oxidase inhibitors for learning and memory
PL373484A1 (en) *	2001-12-10	2005-09-05	Amgen Inc.	Vanilloid receptor ligands and their use in treatments
PA8579701A1 (en) *	2002-08-23	2005-05-24	Pfizer Prod Inc	BETA-LACTAMASA INHIBITOR PROFARMACO
DE10306202A1 (en) *	2003-02-13	2004-08-26	Grünenthal GmbH	2-(hetero)aryl-2-(N-((hetero)aryl)-amino)-acetic acid derivatives useful e.g. for treating anxiety, inflammation, allergy, depression, diarrhea or especially pain is NMDA antagonist
EP1636240A1 (en) *	2003-06-05	2006-03-22	Pfizer Products Inc.	Beta-lactamase inhibitor prodrug
RU2247563C1 (en) *	2003-06-16	2005-03-10	Пятигорская государственная фармацевтическая академия	Method for preparing solid medicinal formulation comprising glucosamine hydrochloride
ATE473967T1 (en) *	2003-11-26	2010-07-15	Pfizer Prod Inc	AMINOPYRAZOLE DERIVATIVES AS GSK-3 INHIBITORS
CA2551952A1 (en) *	2003-12-29	2005-07-21	Sepracor Inc.	Pyrrole and pyrazole daao inhibitors
RU2281755C2 (en) *	2004-04-19	2006-08-20	Пятигорская государственная фармацевтическая академия	Composition - medicinal formulation of anti-arthrosis agent, glucosamine hydrochloride, for rectal using
US20060002999A1 (en) *	2004-06-17	2006-01-05	Forest Laboratories, Inc.	Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
EP1904066B1 (en)	2005-07-06	2018-05-23	Sunovion Pharmaceuticals Inc.	COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS
CA2636324C (en) *	2006-01-06	2012-03-20	Sepracor Inc.	Cycloalkylamines as monoamine reuptake inhibitors
WO2007081542A2 (en) *	2006-01-06	2007-07-19	Sepracor Inc.	Tetralone-based monoamine reuptake inhibitors
DK2013835T3 (en)	2006-03-31	2015-12-14	Sunovion Pharmaceuticals Inc	Preparation of chiral amides and AMINES
US7579370B2 (en) *	2006-06-30	2009-08-25	Sepracor Inc.	Fused heterocycles
US7884124B2 (en) *	2006-06-30	2011-02-08	Sepracor Inc.	Fluoro-substituted inhibitors of D-amino acid oxidase
US20080082066A1 (en) *	2006-10-02	2008-04-03	Weyerhaeuser Co.	Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
EP1942104A1 (en)	2006-12-20	2008-07-09	sanofi-aventis	Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
US7902252B2 (en) *	2007-01-18	2011-03-08	Sepracor, Inc.	Inhibitors of D-amino acid oxidase
ZA200904686B (en)	2007-01-18	2010-09-29	Sepracor Inc	Inhibitiors of D-amino acid oxidase
RU2470011C2 (en)	2007-05-31	2012-12-20	Сепракор Инк.	Cycloalkylamines, containing phenyl as substituent, as inhibitors of monoamine reuptake
WO2009151498A2 (en) *	2008-03-28	2009-12-17	Forest Laboratories Holdings Limited	Memantine formulations
US20100120740A1 (en) *	2008-08-07	2010-05-13	Sepracor Inc.	Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US20110319463A1 (en) *	2009-03-10	2011-12-29	Saten Pharamaceuticals Co., Ltd.	Preventive or therapeutic agents for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivatives or salts thereof as active ingredients
US20110034434A1 (en) *	2009-08-07	2011-02-10	Sepracor Inc.	Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US9737531B2 (en)	2012-07-12	2017-08-22	Glytech, Llc	Composition and method for treatment of depression and psychosis in humans
AU2015253099B2 (en)	2014-04-30	2019-07-18	National Chiao Tung University	Use of known compounds as D-amino acid oxidase inhibitors
CN110234635B (en)	2016-09-14	2023-03-10	宇凤·简·曾	Novel substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors
AU2018284335A1 (en)	2017-06-12	2020-01-30	Glytech Llc.	Treatment of depression with NMDA antagonists and D2/5HT2A or selective 5HT2A antagonists
CN112707874A (en) *	2020-12-29	2021-04-27	广东中科药物研究有限公司	Antiviral compound and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3010971A (en) *	1960-08-04	1961-11-28	Smith Kline French Lab	Cyclopropylamine derivatives and processes for their preparation
DK500285A (en) *	1984-11-02	1986-05-03	Glaxo Group Ltd	cephalosporin antibiotics
US4960786A (en) *	1989-04-24	1990-10-02	Merrell Dow Pharmaceuticals Inc.	Excitatory amino acid antagonists
JPH0347123A (en) *	1989-05-05	1991-02-28	G D Searle & Co	Therapeutic composition for cns disease con- taining indole-2-carboxylate compounds
DE69118539T2 (en) *	1990-07-16	1996-09-19	Merrell Dow Pharmaceuticals Inc., Cincinnati, Ohio	Excitatory amino acid antagonists
US5284862A (en) *	1991-03-18	1994-02-08	Warner-Lambert Company	Derivatives of 2-carboxyindoles having pharmaceutical activity
US5145845A (en) *	1991-05-14	1992-09-08	Warner-Lambert Co.	Substituted 2-carboxylindoles having pharmaceutical activity

1992
- 1992-04-16 GB GB929208492A patent/GB9208492D0/en active Pending
1993
- 1993-04-14 ZA ZA932642A patent/ZA932642B/en unknown
- 1993-04-15 AU AU36923/93A patent/AU666927B2/en not_active Ceased
- 1993-04-15 US US08/046,947 patent/US5373018A/en not_active Expired - Fee Related
- 1993-04-15 JP JP5517997A patent/JPH07505407A/en active Pending
- 1993-04-15 CH CH1133/93A patent/CH685630A5/en not_active IP Right Cessation
- 1993-04-15 NZ NZ247413A patent/NZ247413A/en unknown
- 1993-04-15 MY MYPI93000690A patent/MY112232A/en unknown
- 1993-04-15 EP EP93201103A patent/EP0568136A1/en not_active Withdrawn
- 1993-04-15 IS IS3994A patent/IS3994A/en unknown
- 1993-04-15 CA CA002094076A patent/CA2094076A1/en not_active Abandoned
- 1993-04-15 SE SE9301241A patent/SE504336C2/en not_active IP Right Cessation
- 1993-04-15 RU RU94045915A patent/RU2129544C1/en active
- 1993-04-15 BE BE9300371A patent/BE1006343A5/en active
- 1993-04-15 CZ CZ942543A patent/CZ285799B6/en not_active IP Right Cessation
- 1993-04-15 US US08/047,430 patent/US5374649A/en not_active Expired - Fee Related
- 1993-04-15 PL PL93305554A patent/PL176451B1/en unknown
- 1993-04-15 SK SK1241-94A patent/SK281941B6/en unknown
- 1993-04-15 GR GR930100154A patent/GR1001619B/en not_active IP Right Cessation
- 1993-04-15 WO PCT/EP1993/000938 patent/WO1993021153A1/en not_active Ceased
- 1993-04-15 LU LU88248A patent/LU88248A1/en unknown
- 1993-04-15 FR FR9304452A patent/FR2690919B1/en not_active Expired - Fee Related
- 1993-04-15 JP JP5088844A patent/JPH0649027A/en active Pending
- 1993-04-15 IL IL105412A patent/IL105412A/en not_active IP Right Cessation
- 1993-04-15 KR KR1019940703668A patent/KR100264114B1/en not_active Expired - Fee Related
- 1993-04-15 DK DK043193A patent/DK169890B1/en active
- 1993-04-15 GB GB9307808A patent/GB2266091B/en not_active Expired - Fee Related
- 1993-04-15 CA CA002094075A patent/CA2094075A1/en not_active Abandoned
- 1993-04-15 AT AT0075293A patent/AT403917B/en not_active IP Right Cessation
- 1993-04-15 CA CA002094073A patent/CA2094073A1/en not_active Abandoned
- 1993-04-15 ES ES09300771A patent/ES2105924B1/en not_active Expired - Lifetime
- 1993-04-15 HU HU9402975A patent/HU217964B/en not_active IP Right Cessation
- 1993-04-15 IT IT93RM000236A patent/IT1265325B1/en active IP Right Grant
- 1993-04-15 MX MX9302195A patent/MX9302195A/en not_active IP Right Cessation
- 1993-04-15 US US08/047,429 patent/US5374648A/en not_active Expired - Fee Related
- 1993-04-15 CN CN93105797A patent/CN1042331C/en not_active Expired - Fee Related
- 1993-04-15 RO RO94-01658A patent/RO113242B1/en unknown
- 1993-04-16 AP APAP/P/1993/000524A patent/AP480A/en active
- 1993-04-16 GE GEAP19932602A patent/GEP19991704B/en unknown
- 1993-05-06 TW TW082103531A patent/TW224457B/zh active
1994
- 1994-10-10 OA OA60570A patent/OA10103A/en unknown
- 1994-10-12 FI FI944800A patent/FI106198B/en active
- 1994-10-14 NO NO943913A patent/NO301879B1/en not_active IP Right Cessation
- 1994-10-14 BG BG99111A patent/BG62136B1/en unknown
- 1994-12-08 US US08/351,762 patent/US5510367A/en not_active Expired - Fee Related
1995
- 1995-06-29 HU HU95P/P00538P patent/HU211826A9/en unknown
1997
- 1997-04-22 BR BR1100323-5A patent/BR1100323A/en active IP Right Grant
- 1997-06-26 HK HK95797A patent/HK95797A/en not_active IP Right Cessation
1998
- 1998-04-30 CY CY9802038A patent/CY2038B1/en unknown

Also Published As

Publication number	Publication date
GB2266091B (en)	1995-08-09
RU94045915A (en)	1996-09-10
ITRM930236A1 (en)	1994-10-15
EP0568136A1 (en)	1993-11-03
CA2094073A1 (en)	1993-10-17
CN1085212A (en)	1994-04-13
GB2266091A (en)	1993-10-20
ZA932642B (en)	1994-01-10
SE9301241L (en)	1993-10-17
GEP19991704B (en)	1999-08-05
DK43193A (en)	1993-10-17
GB9208492D0 (en)	1992-06-03
CN1042331C (en)	1999-03-03
DK43193D0 (en)	1993-04-15
RO113242B1 (en)	1998-05-29
NO301879B1 (en)	1997-12-22
ITRM930236A0 (en)	1993-04-15
NO943913L (en)	1994-12-14
MY112232A (en)	2001-05-31
AU3692393A (en)	1993-10-21
SE9301241D0 (en)	1993-04-15
FI944800L (en)	1994-10-12
AU666927B2 (en)	1996-02-29
HU9402975D0 (en)	1995-02-28
GR1001619B (en)	1994-07-29
CZ285799B6 (en)	1999-11-17
BE1006343A5 (en)	1994-07-26
IT1265325B1 (en)	1996-10-31
CH685630A5 (en)	1995-08-31
WO1993021153A1 (en)	1993-10-28
IL105412A0 (en)	1993-08-18
JPH0649027A (en)	1994-02-22
US5374648A (en)	1994-12-20
ATA75293A (en)	1997-11-15
LU88248A1 (en)	1994-03-01
CA2094075A1 (en)	1993-10-17
TW224457B (en)	1994-06-01
BR1100323A (en)	2000-06-27
MX9302195A (en)	1994-03-31
ES2105924B1 (en)	1998-07-01
AP9300524A0 (en)	1993-04-30
JPH07505407A (en)	1995-06-15
BG99111A (en)	1995-05-31
GB9307808D0 (en)	1993-06-02
AP480A (en)	1996-03-22
CA2094076A1 (en)	1993-10-17
RU2129544C1 (en)	1999-04-27
DK169890B1 (en)	1995-03-27
IL105412A (en)	1998-02-22
US5510367A (en)	1996-04-23
OA10103A (en)	1996-12-18
BG62136B1 (en)	1999-03-31
FR2690919A1 (en)	1993-11-12
SE504336C2 (en)	1997-01-13
NZ247413A (en)	1995-12-21
CZ254394A3 (en)	1995-07-12
FR2690919B1 (en)	1995-05-05
PL176451B1 (en)	1999-05-31
FI944800A0 (en)	1994-10-12
SK124194A3 (en)	1995-05-10
ES2105924A1 (en)	1997-10-16
NO943913D0 (en)	1994-10-14
US5374649A (en)	1994-12-20
CY2038B1 (en)	1998-04-30
KR100264114B1 (en)	2000-11-01
US5373018A (en)	1994-12-13
FI106198B (en)	2000-12-15
AT403917B (en)	1998-06-25
HU217964B (en)	2000-05-28
HK95797A (en)	1997-08-08
HU211826A9 (en)	1995-12-28
SK281941B6 (en)	2001-09-11
HUT70526A (en)	1995-10-30

Publication	Publication Date	Title
IS3994A (en)	1993-10-17	An analogous method for the production of indole derivatives
IS3873A (en)	1992-12-04	An analogous method for the production of crystalline oxathiol derivatives
IS4148A (en)	1994-10-16	An analogous method for the production of 1,5 Benzodiazepine derivatives
IS4201A (en)	1995-03-01	Process for the production of Benzofuran derivatives
IS1708B (en)	1998-12-16	An analogous method for the production of water-soluble camptothecin derivatives
IS4219A (en)	1995-04-15	Method for producing Indole derivatives
IS1611B (en)	1996-10-18	Similar methods for the production of Quinuclidine derivatives
IS3954A (en)	1993-06-05	An analogous method for the production of new peptide derivatives
IS3915A (en)	1993-03-19	Process for the production of benzanilide derivatives
IS3914A (en)	1993-03-19	Process for the production of benzanilide derivatives
IS4121A (en)	1994-07-21	An analogous method for the preparation of 2,6-Diaminopurine derivatives
IS3945A (en)	1993-05-15	Process for the production of acetic acid derivatives
IS1653B (en)	1997-06-20	An analogous method for the production of new glucocorticosteroids
IS4244A (en)	1995-06-23	Method for producing and using Indoline derivatives
FI940769A7 (en)	1994-08-20	Process for preparing 2-aminoazole derivatives
IS3827A (en)	1992-09-28	An analogous method for the production of pyrrole [2,3 b] pyridines
IS4190A (en)	1995-01-21	An analogous method for the preparation of 1.5 benzodiazepine derivatives
IS4980A (en)	1999-02-16	Methods and intermediates for the production of substituted chromonol derivatives
ZA985918B (en)	2000-01-10	Process for the production of indole derivatives.
IS4033A (en)	1993-12-18	Similar method for the production of isobenzofuranyl derivatives and intermediates for use with the method
IS4079A (en)	1993-06-20	Intermediates for the production of substituted benzimidazoles
FI953361L (en)	1995-07-07	Process for preparing substituted indolone derivatives
FI910756A7 (en)	1991-08-21	Fermentation method for the production of staurosporine
IS4707A (en)	1998-03-31	Process for the production of dioxoazabicyclohexanes
FI931845A0 (en)	1993-04-23	PROCEDURE FOR THE PRODUCTION OF VEGETABLES AVAILABLE